Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pectoralis Nerve Block for Hemodynamic Stability in OPCAB
NCT03734848Phase 1Completed
- Sponsor
- Tanta University
- Start
- Jan 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of bupivacaine in pain (2 arms), sponsored by Tanta University. Primary endpoints: Changes in Heart Rate, Changes in Mean Arterial Blood Pressure and 3 more. Started Jan 2016; status: completed.
02
Drugs
bupivacaine
03
Conditions
pain
Beyond the preview
Go deeper on NCT03734848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03734848.